Volume 12 - Issue 10 - October, 2004
Cardiovascular Laboratory Performance Improvement: A 27-Month Angioplasty Program Evaluation
- Thu, 6/19/08 - 2:00pm
- 0 Comments
Should angioplasty and stent placement (PCI) be done in a hospital without on-site open heart surgery? This question is plaguing the entire United States right now. However, when you are an island in the middle of the Caribbean Sea and you do not have an open heart surgery program, then PCI or thrombolytics could be the only choices that your patients may have to survive.
In June 2000, a cardiovascular laboratory was opened at the Governor Juan F. Luis Hospital and Medical center in St. Croix, United States Virgin Islands. At that time, only diagnostic procedures were being conducted. How
Email Discussion Group: IABP Removal by Registered Nurses?
- Thu, 6/19/08 - 2:00pm
- 1 Comments
Topic Under Discussion:
IABP removal by registered nurses
I am trying to find information about the practice of removing IABP by registered nurses. Do you have any information about this practice within the cath lab or ICU areas?
Luz Kuilan, RN, MSN, CCRN
Clinical Education Specialist-BG
Broward General Medical Center, Fort Lauderdale, FL
CCL can; but RNs, not sure
In our facility, cath lab personnel are trained/certified to remove IABPs, and can do so without the presence of a MD. I am not sure if RNs can be certified to do the same, though I don't know
The Meeting Season
- Thu, 6/19/08 - 2:00pm
- 0 Comments
Fall always means a sharp increase in the amount of invasive cardiology-related information, news, and reported research. It’s tough to travel to the many fall meetings on a regular basis (empties the budget fast), let alone follow the research that tumbles out daily. Some pf us resort to relying on the equivalent of sound bites, whether by scanning abstracts, checking out internet newsletter and website highlights, or even conversations with fellow professionals and physicians. (Of course, CLD is confident that our readers perform a thorough, end-to-end read of this publication each month.
The Arkansas RCIS A New "Limited Specialty License"
- Thu, 6/19/08 - 2:00pm
- 0 Comments
The information below is compiled from: www. healthyarkansas.com/rtl
What is a Limited Specialty License?
This new license type is for individuals other than a Licensed Practitioner, Radiologic Technologists, or Licensed Technologists, who while under the supervision of a License Practitioner, operates medical equipment emitting ionizing radiation for diagnostic purposes on human beings that are limited to specific Invasive Cardiovascular Imaging Procedures, with RCIS credentialing. Must attach CCI-RCIS card along with application.
From the FAQ section of the website.
News from the Transcatheter Cardiovascular Therapeutics Meeting (TCT): Part I
- Thu, 6/19/08 - 2:00pm
- 0 Comments
Boston Scientific Announces Two-Year Follow-Up Data from the TAXUS II Clinical Trial
Boston Scientific Corporation announced two-year follow-up data from its TAXUS II paclitaxel-eluting stent system clinical trial. The results provided two-year clinical outcomes, as well as the largest, long-term prospective quantitative coronary angiography (QCA) and intravascular ultrasound (IVUS) follow-up data of any drug-eluting stent trial to date. The data demonstrated that the safety and efficacy benefits associated with the Taxus stent system were maintained at two years. The company made
News from the Transcatheter Cardiovascular Therapeutics Meeting (TCT): Part II
- Thu, 6/19/08 - 2:00pm
- 1 Comments
continued from previous page
Heartlab Provides Global DICOM Connectivity for the 2004 TCT Conference
Hospital sites performing live cases utilize Heartlab’s CardioNow DICOM study-sharing
software to electronically transfer cases to the Washington Convention Center.
Heartlab’s CardioNow web-based technology for DICOM study sharing was utilized during the 2004 TCT conference to connect sites broadcasting live cases from around the world with conference attendees in Washington, D.C. One of the most anticipated events of this conference was the live case sessions t
Clinical & Industry News: Zommax, Type 2 Diabetes
- Thu, 6/19/08 - 2:00pm
- 1 Comments
Abbott Vascular Devices Enrolls First Patient in Clinical Trial of the ZoMaxx Drug-Eluting Coronary Stent
Abbott Vascular Devices, a division of Abbott Laboratories, announced the enrollment of the first patient in the ZOMAXX I drug-eluting coronary stent clinical trial.
ZOMAXX I is a 400-patient prospective randomized clinical trial that will be conducted in more than 30 centers in Europe, Australia and New Zealand. The study compares Abbott’s ZoMaxx drug-eluting coronary stent to Boston Scientific’s Taxus Express2 drug-eluting stent with a primary endpoint of 9-month in-
Time in the Cath Lab & Outside the Lab
- Thu, 6/19/08 - 2:00pm
- 0 Comments
Letter to the Editor
Dear Editor,
Our lab was reading your Letter from the Editor (Have you spent 10 years in the cath lab? Cath Lab Digest, September 2003) and was amazed at the idea that 10 years or more experience is elite. We have 15 staff in our 4-room lab. Of those 15, eleven staff members have more than 13 years experience, three have 4 years and one has 2 years.
Vickie Bligh, RN
Providence Everett Medical Center Cath Lab
Everett, Washington
Victoria.Bligh@providence.org
Outside the Lab
Cath lab staff from University Community Hospital of Tam
Drug-Eluting Stent Solutions
- Thu, 6/19/08 - 2:00pm
- 0 Comments
How does the TAXUS VI clinical trial fit into the TAXUS Stent clinical trial series?
The TAXUS VI clinical trial is the most recent of six clinical trials over four years to study the safety and efficacy of Boston Scientific's TAXUS Express® Paclitaxel-Eluting Stent. TAXUS VI was designed to evaluate the safety and efficacy of the moderate-release doses of paclitaxel in longer, more complex lesions.
What is the significance of the sub-population data in this study?
The emphasis on studying high-risk patient types was a key component of TAXUS VI. Twenty-eight percent
Experience with the Chito-SealTM Topical Hemostasis Pad at Glendale Memorial Heart Center
- Thu, 6/19/08 - 2:00pm
- 0 Comments
The Glendale Memorial Heart Center was established in 1992 by a core group of cardiologists and cardiac surgeons, who believed in the need to provide exceptional cardiac care to the community. Today, the Heart Center is recognized for its dedication and commitment to the prevention and treatment of cardiac disease. Due in great part to our well-aligned group of cardiologists and cardiovascular surgeons, in 2000 and, again in 2002, Glendale Memorial was the area’s only nationally recognized Top 100 heart hospital. This designation represents exceptional quality in the treatment of AMI, CHF, C
- « Previous
- | Page 1 of 2 |
- Next »
